01 1Suzhou Lixin Pharmaceutical
01 1NILOTINIB HYDROCHLORIDE MONOHYDRATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-15
Pay. Date : 2024-07-02
DMF Number : 40014
Submission : 2024-05-28
Status : Active
Type : II
20
Shandong Lixin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is NILOTINIB HYDROCHLORIDE MONOHYDRATE, with a corresponding US DMF Number 40014.
Remarkably, this DMF maintains an Active status since its submission on May 28, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 15, 2024, and payment made on July 02, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
